Texas Yale Capital Corp.
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1332342
ST. PETERSBURG, FL
Position in VRTX
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$2,195,049
+$255,280 QoQ
Shares Held
4,419
+1.7% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#651
of 1,735 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Texas Yale Capital Corp. holds $3,520,339 across 3 Biotechnology names. VRTX ranks #1 (62.4% of the industry book) .
All Filings in VRTX
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,195,049 | 4,419 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $1,939,769 | 4,344 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $1,935,393 | 4,269 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $1,601,024 | 4,088 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $1,766,553 | 3,968 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $1,984,368 | 4,093 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $1,648,251 | 4,093 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $1,957,056 | 4,208 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,972,373 | 4,208 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $1,763,166 | 4,218 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $1,537,637 | 3,779 | Shares | Sole | 2024-02-13 | |
| No filing history on record for this holder in this stock. | ||||||